Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A Study to Test the Safety and Body’s Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Belgium
  • A study to test the safety and immune response of PHH-1V111 vaccine against COVID-19 variants in adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study of mRNA-based seasonal influenza vaccine to evaluate immune response and safety in adults 18 years and older

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study of H5N8 influenza vaccine in adults previously vaccinated with H5N1/MF59 vaccine compared to those never vaccinated with H5 vaccine

    Not recruiting

    3 1 1 1
    Belgium Italy
  • Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study of acellular pertussis vaccine and its effect on whooping cough colonization in healthy adults using controlled human infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Finland Italy Spain
  • Study of N-803 combined with BCG treatment for patients with early-stage bladder cancer that has not invaded the muscle wall

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of H5N8 Influenza Vaccine Response in Adults Previously Vaccinated with H5N1 Vaccine Compared to Those Never Vaccinated Against H5 Influenza

    Not recruiting

    3 1 1 1
    Norway
  • Study of mRNA-based seasonal influenza vaccine combinations compared to standard influenza vaccines in adults aged 18 and older

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium
  • Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

    Not recruiting

    3 1 1 1
    Belgium Bulgaria Estonia Finland Spain
  • Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Germany Spain